tiprankstipranks
Advertisement
Advertisement

HK:6160 Stock Latest News

BeOne Medicines: FDA grants Priority Review to sBLA for tevimbra/ziihera combo
The FlyBeOne Medicines: FDA grants Priority Review to sBLA for tevimbra/ziihera combo
2d ago
ONC
BeOne Medicines Posts U.S. Proxy Materials, Highlights Cross-Border Disclosure
PremiumCompany Announcements
BeOne Medicines Posts U.S. Proxy Materials, Highlights Cross-Border Disclosure
3d ago
6160
BeOne Medicines Sets 2026 AGM and Moves to Web-First Proxy Distribution
PremiumCompany Announcements
BeOne Medicines Sets 2026 AGM and Moves to Web-First Proxy Distribution
3d ago
6160
BeOne Medicines Sets Record Date for 2026 AGM to Define Voting Rights
PremiumCompany Announcements
BeOne Medicines Sets Record Date for 2026 AGM to Define Voting Rights
3d ago
6160
BeOne Medicines Sets May 6 Date for First‑Quarter 2026 Results and Investor Call
PremiumCompany Announcements
BeOne Medicines Sets May 6 Date for First‑Quarter 2026 Results and Investor Call
9d ago
6160
BeOne Medicines Revamps Board and Committees Ahead of 2026 AGM
PremiumCompany AnnouncementsBeOne Medicines Revamps Board and Committees Ahead of 2026 AGM
15d ago
6160
BeOne Medicines price target lowered to $411 from $412 at Truist
Premium
The Fly
BeOne Medicines price target lowered to $411 from $412 at Truist
23d ago
ONC
BeOne Medicines Grants RSUs to 154 Employees Under 2016 Incentive Plan
Premium
Company Announcements
BeOne Medicines Grants RSUs to 154 Employees Under 2016 Incentive Plan
23d ago
6160
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
PremiumRatings
Buy Rating on BeOne Medicines: Strong Brukinsa Positioning, Deep Oncology Pipeline, and Attractive Valuation Ahead of 2026 Milestones
1M ago
ONC
BeOne Medicines initiated with an Outperform at Wolfe Research
PremiumThe Fly
BeOne Medicines initiated with an Outperform at Wolfe Research
1M ago
ONC
BeOne Medicines Swings to Profit on 40% Revenue Surge in 2025
PremiumCompany Announcements
BeOne Medicines Swings to Profit on 40% Revenue Surge in 2025
1M ago
6160
BeOne Medicines treatment of hepatocellular carcinoma granted orphan designation
PremiumThe Fly
BeOne Medicines treatment of hepatocellular carcinoma granted orphan designation
1M ago
ONC
BeOne Medicines downgraded to Hold from Buy at Jefferies
PremiumThe FlyBeOne Medicines downgraded to Hold from Buy at Jefferies
2M ago
ONC
BeOne Medicines Updates HKEX Waivers and Compliance Disclosures
Premium
Company Announcements
BeOne Medicines Updates HKEX Waivers and Compliance Disclosures
2M ago
6160
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
Premium
Company Announcements
BeOne Medicines Updates on Employee Share Purchase Plan Uptake
2M ago
6160
BeOne Medicines Aligns 2025 Results With Dual Hong Kong and U.S. Reporting Rules
PremiumCompany Announcements
BeOne Medicines Aligns 2025 Results With Dual Hong Kong and U.S. Reporting Rules
2M ago
6160
BeOne Medicines Opens New 2018 Employee Share Purchase Plan Offering Period
PremiumCompany Announcements
BeOne Medicines Opens New 2018 Employee Share Purchase Plan Offering Period
2M ago
6160
BeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan
PremiumCompany Announcements
BeOne Medicines Grants New RSUs to 188 Employees Under Incentive Plan
2M ago
6160
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs
PremiumMarket News
KURE vs. VHT: Comparing China and U.S. Healthcare ETFs
2M ago
JNJ
LLY
Zymeworks, Royalty Pharma enter $250M royalty-backed note financing
PremiumThe FlyZymeworks, Royalty Pharma enter $250M royalty-backed note financing
2M ago
ONC
JAZZ
BeOne Medicines price target raised to $412 from $400 at Truist
Premium
The Fly
BeOne Medicines price target raised to $412 from $400 at Truist
2M ago
ONC
BeOne Medicines price target raised to $425 from $417 at RBC Capital
Premium
The Fly
BeOne Medicines price target raised to $425 from $417 at RBC Capital
2M ago
ONC

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >